MCID: LRY018
MIFTS: 57

Laryngeal Squamous Cell Carcinoma malady

Skin diseases, Oral diseases, Cancer diseases categories

Summaries for Laryngeal Squamous Cell Carcinoma

About this section
Sources:
32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
MalaCards: Laryngeal Squamous Cell Carcinoma, also known as epidermoid carcinoma of the larynx, is related to squamous cell carcinoma and cervical squamous cell carcinoma. An important gene associated with Laryngeal Squamous Cell Carcinoma is BIRC5 (baculoviral IAP repeat containing 5), and among its related pathways are Pathways in cancer and Rho Family GTPases. The compounds retinoic acid and oligonucleotide have been mentioned in the context of this disorder. Affiliated tissues include lymph node, endothelial and thyroid, and related mouse phenotypes are cellular and immune system.

Aliases & Classifications for Laryngeal Squamous Cell Carcinoma

About this section
Sources:
8Disease Ontology, 10DISEASES, 44Novoseek, 60UMLS, 39NCIt, 56SNOMED-CT
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases
Anatomical: Skin diseases, Oral diseases


Aliases & Descriptions:

laryngeal squamous cell carcinoma 8 10 44 60
epidermoid carcinoma of the larynx 8
squamous cell carcinoma of larynx 8


External Ids:

Disease Ontology8 DOID:2876
SNOMED-CT56 405822008
NCIt39 C4044

Related Diseases for Laryngeal Squamous Cell Carcinoma

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Laryngeal Squamous Cell Carcinoma via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 161)
idRelated DiseaseScoreTop Affiliating Genes
1squamous cell carcinoma32.4NME1, EIF4E, MKI67, CCND1
2cervical squamous cell carcinoma30.8SKP2, CDKN2A, MKI67
3papilloma30.7PTEN, FLT4
4papillary carcinoma30.5NME1, MKI67, VEGFC, IFI27
5papillary thyroid carcinoma30.5PTEN, VEGFC, IFI27, CCND1
6adenocarcinoma30.3GSTT1, BCL2, PTEN, TERT, SKP2, BIRC5
7retinoblastoma30.3BCL2, TERT, SKP2, BIRC5, NME1, PCNA
8lung adenocarcinoma30.3GSTT1, BCL2, TERT, SKP2, BIRC5, CDKN2A
9parathyroid carcinoma30.3MKI67, CCND1
10laryngeal carcinoma11.6
11laryngitis11.6
12cervicitis10.6
13squamous cell papilloma10.5
14laryngeal disease10.5
15thyroiditis10.5
16laryngeal small cell carcinoma10.4
17small cell carcinoma10.4
18in situ carcinoma10.4
19skin squamous cell carcinoma10.4
20papillary squamous carcinoma10.4
21pharyngitis10.4
22nasopharyngitis10.4
23larynx squamous papilloma10.2
24sarcocystosis10.2
25conjunctivitis10.2
26epidermolysis bullosa10.2
27histoplasmosis10.2
28hodgkin's lymphoma10.2
29lipoma10.2
30lung squamous cell carcinoma10.2
31melanoma10.0GSTT1, BCL2, PTEN, TERT, SKP2, BIRC5
32hepatocellular carcinoma10.0GSTT1, BCL2, PTEN, TERT, SKP2, BIRC5
33stomach cancer10.0BCL2, PTEN, TERT, SKP2, BIRC5, NME1
34colorectal cancer10.0BCL2, PTEN, TERT, SKP2, BIRC5, NME1
35adenoma10.0GSTT1, BCL2, TERT, SKP2, BIRC5, NME1
36leukemia10.0GSTT1, BCL2, TERT, SKP2, BIRC5, NME1
37ovarian cancer10.0BCL2, PTEN, TERT, SKP2, BIRC5, NME1
38prostate cancer10.0GSTT1, BCL2, PTEN, TERT, SKP2, BIRC5
39non-small cell lung carcinoma10.0BCL2, TERT, SKP2, BIRC5, NME1, PCNA
40cervical cancer10.0GSTT1, BCL2, TERT, SKP2, BIRC5, NME1
41squamous cell carcinoma of the head and neck10.0GSTT1, BCL2, BIRC5, NME1, MMP13, EIF4E
42transitional cell carcinoma10.0GSTT1, BIRC5, NME1, NAT2, PCNA, CDKN2B
43oral cancer10.0GSTT1, TERT, SKP2, BIRC5, PCNA, CDKN2A
44gastric adenocarcinoma10.0GSTT1, BCL2, BIRC5, NME1, MMP13, NAT2
45bladder carcinoma10.0GSTT1, TERT, BIRC5, NAT2, CDKN2B, CDKN2A
46kidney cancer10.0GSTT1, BIRC5, NME1, PCNA, MKI67, VEGFC
47esophageal cancer10.0NME1, MMP13, PCNA, CDKN2B, CDKN2A, VEGFC
48laryngeal benign neoplasm10.0GSTT1, TERT, NME1, NAT2, PCNA, MKI67
49nasopharynx carcinoma10.0GSTT1, BCL2, TERT, NME1, NAT2, PCNA
50b-cell lymphomas10.0BCL2, SKP2, BIRC5, CDKN2B, CDKN2A, MKI67

Graphical network of the top 20 diseases related to Laryngeal Squamous Cell Carcinoma:



Diseases related to laryngeal squamous cell carcinoma

Clinical Features for Laryngeal Squamous Cell Carcinoma

About this section

Drugs & Therapeutics for Laryngeal Squamous Cell Carcinoma

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Laryngeal Squamous Cell Carcinoma

Drug clinical trials:

Search ClinicalTrials for Laryngeal Squamous Cell Carcinoma

Search NIH Clinical Center for Laryngeal Squamous Cell Carcinoma

Search CenterWatch for Laryngeal Squamous Cell Carcinoma

Genetic Tests for Laryngeal Squamous Cell Carcinoma

About this section

Anatomical Context for Laryngeal Squamous Cell Carcinoma

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Laryngeal Squamous Cell Carcinoma:

32
Lymph node, Endothelial, Thyroid, Lung, Skin, T cells, Pituitary

Animal Models for Laryngeal Squamous Cell Carcinoma or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Laryngeal Squamous Cell Carcinoma:

36 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:000538411.6CDKN2B, CDKN2A, CTSD, AURKA, CCND1, PCNA
2MP:000538711.5CDKN2A, VEGFC, FLT4, CTSD, CCND1, CDKN2B
3MP:000539711.4CCND1, CTSD, CDKN2A, CDKN2B, PCNA, NME1
4MP:000200611.3CCND1, AURKA, CDKN2A, CDKN2B, EIF4E, NME1
5MP:000537811.3CDKN2A, FLT4, CTSD, AURKA, CCND1, PCNA
6MP:001076811.3VEGFC, FLT4, CTSD, AURKA, CCND1, CDKN2A
7MP:000538911.2CDKN2B, CDKN2A, FLT4, CCND1, PCNA, NAT2
8MP:000537911.2CCND1, CTSD, CDKN2A, CDKN2B, NME1, SKP2
9MP:000537611.0GSTT1, MMP13, NAT2, CTSD
10MP:000538111.0CTSD, FLT4, CDKN2A, TERT, PTEN, BCL2
11MP:001077110.7CCND1, CDKN2A, CDKN2B, MMP13, NME1, PTEN

Publications for Laryngeal Squamous Cell Carcinoma

About this section
Sources:
50PubMed
See all sources

Articles related to Laryngeal Squamous Cell Carcinoma:

(show top 50)    (show all 605)
idTitleAuthorsYear
1
Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain. (24001612)
2014
2
miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). (24055400)
2013
3
Cigarette smoking and alcohol ingestion as risk factors for laryngeal squamous cell carcinoma at kenyatta national hospital, kenya. (24179405)
2012
4
Expression and their significance of Jab1 p27kip1 in laryngeal squamous cell carcinoma and Hep-2 cells]. (22675932)
2012
5
Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma. (22009483)
2012
6
Methylthioadenosine phosphorylase inactivation depends on gene deletion in laryngeal squamous cell carcinoma. (23020581)
2012
7
Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma. (23231769)
2012
8
Expression of HMGB1 protein in laryngeal squamous cell carcinoma and its clinical significance]. (22780932)
2012
9
Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice. (21496344)
2011
10
Establishment of a Cell Line (CNUH-HNSCC-1) Derived from an Advanced Laryngeal Squamous Cell Carcinoma. (22111066)
2011
11
Genome-wide evidence of XPC alteration in laryngeal squamous cell carcinomas. (22126485)
2011
12
Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene. (21896986)
2010-2011
13
Assessment of disease-free survival in patients with laryngeal squamous cell carcinoma treated with radiotherapy associated or not with chemotherapy. (20549084)
2010
14
Survival after organ preserving treatment for T4a laryngeal squamous cell carcinoma. (20929963)
2010
15
STAT3 blockade with shRNA enhances radiosensitivity in Hep-2 human laryngeal squamous carcinoma cells. (20043094)
2010
16
Association between human papillomavirus infection and laryngeal squamous cell carcinoma. (20419817)
2010
17
Is neck dissection necessary for early-stage laryngeal squamous cell carcinoma of the epiglottis or not? (19214902)
2009
18
Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation. (19331217)
2009
19
Expression of Livin in laryngeal squamous cell carcinoma and relationship with bFGF]. (18476630)
2008
20
Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of laryngeal squamous cell carcinoma]. (18826096)
2008
21
Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. (18825407)
2008
22
Expression of angiopoietin-1,2 and its relationship with angiogenesis in laryngeal squamous cell carcinoma]. (19086654)
2008
23
Clinical significance and expression of FLIP and PTEN protein in laryngeal squamous cell carcinoma]. (17441421)
2007
24
Expression and role of survivin in laryngeal squamous cell carcinoma and laryngeal papilloma in adults]. (17634026)
2007
25
Combined modality treatment of laryngeal squamous cell carcinoma. (17338653)
2007
26
High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma. (16428200)
2006
27
67-kDa laminin receptor in human laryngeal squamous cell carcinoma. (16481804)
2006
28
CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma. (16979866)
2006
29
Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma]. (16248506)
2005
30
Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. (15763643)
2005
31
The expression and correlation of eIF4E and VEGF in laryngeal squamous cell carcinoma]. (16124648)
2005
32
Expression of extracellular matrix metalloproteinase inducer in laryngeal squamous cell carcinoma]. (16176007)
2005
33
Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma]. (15522186)
2004
34
Association between p53 gene mutations and tobacco and alcohol exposure in laryngeal squamous cell carcinoma. (15023836)
2004
35
The expression of VEGF and iNOS in laryngeal squamous cell carcinoma and its clinical significance]. (15831042)
2004
36
Expression of hypoxia inducible factor-1alpha and its relationship to apoptosis and proliferation in human laryngeal squamous cell carcinoma. (15791865)
2004
37
A systematic review of case-control studies of human papillomavirus infection in laryngeal squamous cell carcinoma. (15270812)
2004
38
Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis. (15361296)
2004
39
The study on the expression of tumor-suppressor gene p15 and Rb in laryngeal squamous cell carcinomas]. (14658190)
2003
40
Study on the expression of the metastasis suppressor gene KAI1 in laryngeal squamous cell carcinoma]. (15040100)
2003
41
Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma. (11809526)
2002
42
Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. (10782883)
2000
43
The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma]. (10875157)
1999
44
MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation. (9267820)
1997
45
Significance of p16 and C-myc expression in the laryngeal squamous cell carcinoma]. (10323033)
1997
46
Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. (9426404)
1997
47
Biological characterization of laryngeal squamous-cell carcinoma. (8694553)
1996
48
Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. (8639294)
1996
49
Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. (8521400)
1995
50
Volumetrical and morphological responses of human laryngeal squamous cell carcinoma xenografts treated with fractionated irradiation. (3375986)
1988

Genetic Variations for Laryngeal Squamous Cell Carcinoma

About this section

Expression for genes affiliated with Laryngeal Squamous Cell Carcinoma

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Laryngeal Squamous Cell Carcinoma

Search GEO for disease gene expression data for Laryngeal Squamous Cell Carcinoma.

Pathways for genes affiliated with Laryngeal Squamous Cell Carcinoma

About this section
Sources:
29KEGG, 51QIAGEN, 37NCBI BioSystems Database, 4Cell Signaling Technology, 53Reactome, 12EMD Millipore, 52R&D Systems
See all sources

Pathways related to Laryngeal Squamous Cell Carcinoma according to GeneCards/GeneDecks:

(show all 33)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
111.0BCL2, PTEN, SKP2, BIRC5, CDKN2B, CDKN2A
2
Hide members
11.0CCND1, FLT4, VEGFC, CDKN2A, CDKN2B, PTEN
3
Hide members
11.0FLT4, VEGFC, CDKN2A, EIF4E, TERT, PTEN
410.9BCL2, PTEN, NME1, PCNA, CDKN2B, CCND1
5
Hide members
10.9CCND1, FLT4, VEGFC, EIF4E, PTEN, BCL2
610.9CCND1, FLT4, VEGFC, EIF4E, PTEN, BCL2
7
Hide members
10.9CCND1, AURKA, MKI67, CDKN2A, PCNA, SKP2
810.8TERT, PCNA, CDKN2B, CDKN2A, CCND1
910.8CCND1, CDKN2B, SKP2, PTEN, BCL2
10
Hide members
10.8CCND1, CDKN2A, CDKN2B, PCNA, SKP2
11
Cell cycle Cell cycle (generic schema)
Hide members
10.8CCND1, CDKN2A, CDKN2B, PCNA, SKP2
12
Hide members
10.8CCND1, PCNA, BIRC5, PTEN, BCL2
13
Hide members
10.8CCND1, PCNA, BIRC5, PTEN, BCL2
14
Hide members
10.8BCL2, PTEN, VEGFC, FLT4, CCND1
1510.8TERT, BIRC5, NME1, EIF4E
1610.8SKP2, CDKN2B, CDKN2A, CCND1
17
Hide members
10.8CCND1, CDKN2A, CDKN2B, SKP2
1810.8CCND1, AURKA, PTEN, BCL2
19
Hide members
10.8MMP13, CDKN2B, VEGFC, FLT4
2010.8BCL2, PTEN, CDKN2A, CCND1
21
Hide members
10.8CCND1, CDKN2A, PTEN, BCL2
2210.8CTSD, PCNA, PTEN, BCL2
2310.8CDKN2A, PCNA, PTEN, BCL2
2410.7CCND1, CDKN2B, BCL2
2510.7CCND1, BIRC5, SKP2
26
Hide members
10.7CCND1, CDKN2A, PTEN
2710.7PTEN, CDKN2A, CCND1
2810.7FLT4, EIF4E, PTEN
29
Hide members
10.7PTEN, PCNA, CCND1
30
Hide members
10.7SKP2, PCNA, CDKN2A
31
Hide members
10.6VEGFC, FLT4
32
Hide members
10.6CDKN2B
33
Hide members
10.5AURKA

Compounds for genes affiliated with Laryngeal Squamous Cell Carcinoma

About this section
Sources:
44Novoseek, 24HMDB, 59Tocris Bioscience, 28IUPHAR, 11DrugBank, 49PharmGKB, 2BitterDB
See all sources

Compounds related to Laryngeal Squamous Cell Carcinoma according to GeneCards/GeneDecks:

(show top 50)    (show all 151)
idCompoundScoreTop Affiliating Genes
1retinoic acid44 2413.1BCL2, IFI27, CCND1, CTSD, FLT4, VEGFC
2oligonucleotide4412.0EIF4E, NAT2, PCNA, VEGFC, IFI27, CCND1
3paraffin4412.0VEGFC, MKI67, CDKN2A, PCNA, MMP13, NME1
4vegf4412.0BCL2, PTEN, TERT, BIRC5, NME1, MMP13
5progesterone44 59 28 11 2415.9BCL2, PTEN, SKP2, BIRC5, NME1, EIF4E
6cisplatin44 49 59 1114.8MKI67, CTSD, IFI27, CCND1, CDKN2A, TERT
7oxygen44 2412.8CDKN2A, CTSD, IFI27, FLT4, GSTT1, BCL2
8paclitaxel44 49 1113.6BCL2, PTEN, CTSD, CDKN2A, AURKA, IFI27
9nitric oxide44 11 2413.6CDKN2A, NAT2, EIF4E, MMP13, NME1, BIRC5
10phosphatidylinositol4411.6BCL2, EIF4E, TERT, CTSD, IFI27, CCND1
11pd 98,0594411.6CDKN2B, CCND1, IFI27, VEGFC, EIF4E, MMP13
12ly2940024411.6TERT, BCL2, PTEN, SKP2, BIRC5, EIF4E
13doxorubicin44 49 1113.6IFI27, CTSD, CDKN2A, MKI67, BIRC5, TERT
14genistein44 28 59 2 11 2416.6BCL2, PCNA, CTSD, IFI27, CCND1, TERT
15thymidine44 2412.6CTSD, BIRC5, NME1, PCNA, MKI67, VEGFC
16arsenite44 2412.5CDKN2A, CCND1, PTEN, BCL2, TERT, BIRC5
17testosterone44 59 11 2414.5PTEN, TERT, BIRC5, PCNA, CDKN2A, MKI67
185fluorouracil4411.5CDKN2A, PCNA, NME1, BIRC5, BCL2, TERT
19rapamycin4411.5CCND1, IFI27, FLT4, EIF4E, BIRC5, SKP2
20threonine4411.5TERT, BIRC5, IFI27, EIF4E, MKI67, CDKN2B
21steroid4411.5GSTT1, BIRC5, NME1, EIF4E, CTSD, IFI27
22thymidylate4411.5CCND1, BCL2, TERT, BIRC5, PCNA, CDKN2A
23p0024411.5IFI27, GSTT1, CTSD, BIRC5, SKP2, NME1
24mg 13244 5912.4EIF4E, PCNA, BCL2, IFI27, BIRC5, PTEN
25dexamethasone44 49 28 1114.4NME1, MMP13, NAT2, PCNA, CDKN2A, VEGFC
26tyrosine4411.4CDKN2B, TERT, PTEN, BIRC5, NME1, EIF4E
27n acetylcysteine4411.4BIRC5, TERT, BCL2, PCNA, CDKN2A, IFI27
28tamoxifen44 49 28 1114.4CCND1, PTEN, BIRC5, BCL2, PCNA, MKI67
29serine4411.3AURKA, NME1, MMP13, EIF4E, CDKN2B, MKI67
30eb 108944 5912.3CCND1, PTEN, SKP2, IFI27, BCL2, PCNA
31roscovitine4411.3CDKN2A, PCNA, CCND1, BIRC5, IFI27, BCL2
32methotrexate44 49 1113.2BIRC5, PCNA, MKI67, NAT2, CDKN2A, CDKN2B
33trastuzumab44 49 1113.2CCND1, IFI27, CTSD, VEGFC, BIRC5, PTEN
34agar4411.2CCND1, CDKN2A, PTEN, BIRC5, NME1, EIF4E
35norcantharidin4411.2MKI67, IFI27, CCND1, BIRC5, PCNA
36estradiol44 11 2413.2BIRC5, MKI67, PTEN, CTSD, VEGFC
37adpribose4411.2PCNA, BIRC5, TERT, IFI27, CCND1, BCL2
38etoposide44 49 59 1114.2TERT, EIF4E, CTSD, BCL2
39p000014411.1CCND1, VEGFC, MKI67, CDKN2A, BIRC5
40crcs4411.1BIRC5, PTEN, CCND1, CDKN2A, NME1
41indole-3-carbinol4411.1IFI27, BCL2, CCND1, PTEN, BIRC5
42dutp4411.0CCND1, MKI67, PCNA, BIRC5, BCL2
43sulindac44 1112.0CCND1, IFI27, PCNA, BIRC5, BCL2
44adriamycin4411.0CTSD, BIRC5, TERT, BCL2, CDKN2A, CCND1
45troglitazone44 28 59 1114.0BIRC5, BCL2, PTEN, SKP2, IFI27, CCND1
46cyclophosphamide44 49 1112.9PTEN, CTSD, MKI67, PCNA, GSTT1, BCL2
47vincristine44 49 1112.8MKI67, CCND1
48olomoucine44 1111.8CCND1, PCNA, BCL2, CDKN2A
49chi 24410.7MKI67, NME1, GSTT1, IFI27
50nimbolide4410.4CCND1, PCNA, BIRC5

GO Terms for genes affiliated with Laryngeal Squamous Cell Carcinoma

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Laryngeal Squamous Cell Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1cytosolGO:00582911.3GSTT1, AURKA, CDKN2A, CDKN2B, NAT2, EIF4E

Biological processes related to Laryngeal Squamous Cell Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1mitotic cell cycleGO:00027811.0CCND1, AURKA, CDKN2A, CDKN2B, PCNA, BIRC5
2response to drugGO:04249310.8GSTT1, BCL2, VEGFC, CCND1
3regulation of protein stabilityGO:03164710.8AURKA, CDKN2A, PTEN, BCL2
4G1/S transition of mitotic cell cycleGO:00008210.7SKP2, PCNA
5replicative senescenceGO:09039910.5CDKN2A, TERT
6response to iron ionGO:01003910.3CCND1, BCL2

Molecular functions related to Laryngeal Squamous Cell Carcinoma according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00551511.6BCL2, CCND1, AURKA, CTSD, FLT4, VEGFC
2protein kinase bindingGO:01990110.8CCND1, AURKA, CDKN2A, CDKN2B, NME1, PTEN
3cyclin-dependent protein serine/threonine kinase inhibitor activityGO:00486110.6CDKN2B, CDKN2A
4identical protein bindingGO:04280210.5PCNA, NME1, BIRC5, SKP2, BCL2

Products for genes affiliated with Laryngeal Squamous Cell Carcinoma

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Laryngeal Squamous Cell Carcinoma

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet